Alkem, Dr Lal to make stock market debut on Dec 23

Alkem IPO was oversubscribed 44.29 times, while Dr Lal was also a huge success with 33.41 times oversubscription

Drug maker Alkem Laboratories and diagnostic chain Dr Lal PathLabs, which recently concluded initial public offerings successfully, would list their shares on the stock exchanges on Wednesday. The equity shares would be listed on the BSE and the National Stock Exchange. Alkem and Dr Lal PathLabs have raised about  Rs 1,350 crore and Rs 191 crore, respectively.

Alkem has raised about Rs 1,350 crore at an issue price of Rs 1,050 per share from its IPO, which was oversubscribed 44.29 times. It plans to expand its footprint internationally.

It had a portfolio of 705 brands in the domestic market as on September 30.
 

Dr Lal's IPO too was a huge success with 33.41 times oversubscription. The price band was fixed at Rs 540-550 per share for the Rs 638 crore IPO. It also raised over Rs 191 crore from anchor investors by selling shares at Rs 550 apiece.